BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 34974290)

  • 1. Newly designed breakapart FISH probe helps to identify cases with true MECOM rearrangement in myeloid malignancies.
    Zhao M; Medeiros LJ; Wang W; Tang G; Jung HS; Sfamenos SM; Fang H; Toruner GA; Hu S; Yin CC; Lin P; Gu J; Peng G; You MJ; Khoury JD; Wang SA; Tang Z
    Cancer Genet; 2022 Apr; 262-263():23-29. PubMed ID: 34974290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deciphering the complexities of MECOM rearrangement-driven chromosomal aberrations.
    Tang Z; Tang G; Hu S; Patel KP; Yin CC; Wang W; Lin P; Toruner GA; Ok CY; Gu J; Lu X; Khoury JD; Medeiros LJ
    Cancer Genet; 2019 Apr; 233-234():21-31. PubMed ID: 31109591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular approaches identify a cryptic MECOM rearrangement in a child with a rapidly progressive myeloid neoplasm.
    Capela de Matos RR; Othman MAK; Ferreira GM; Costa ES; Melo JB; Carreira IM; de Souza MT; Lopes BA; Emerenciano M; Land MGP; Liehr T; Ribeiro RC; Silva MLM
    Cancer Genet; 2018 Feb; 221():25-30. PubMed ID: 29405993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atypical 3q26/MECOM rearrangements genocopy inv(3)/t(3;3) in acute myeloid leukemia.
    Ottema S; Mulet-Lazaro R; Beverloo HB; Erpelinck C; van Herk S; van der Helm R; Havermans M; Grob T; Valk PJM; Bindels E; Haferlach T; Haferlach C; Smeenk L; Delwel R
    Blood; 2020 Jul; 136(2):224-234. PubMed ID: 32219447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MECOM: A Very Interesting Gene Involved also in Lymphoid Malignancies.
    Liu K; Tirado CA
    J Assoc Genet Technol; 2019; 45(3):109-114. PubMed ID: 31554743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of myeloid neoplasms with nonclassic 3q26.2/MECOM versus classic inv(3)/t(3;3) rearrangements reveals diverse clinicopathologic features, genetic profiles, and molecular mechanisms of MECOM activation.
    Gao J; Gurbuxani S; Zak T; Kocherginsky M; Ji P; Wehbe F; Chen Q; Chen YH; Lu X; Jennings L; Frankfurt O; Altman J; Sukhanova M
    Genes Chromosomes Cancer; 2022 Feb; 61(2):71-80. PubMed ID: 34668265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. t(3;8)(q26.2;q24) Often Leads to MECOM/MYC Rearrangement and Is Commonly Associated with Therapy-Related Myeloid Neoplasms and/or Disease Progression.
    Tang G; Hu S; Wang SA; Xie W; Lin P; Xu J; Toruner G; Zhao M; Gu J; Doty M; Li S; Medeiros LJ; Tang Z
    J Mol Diagn; 2019 Mar; 21(2):343-351. PubMed ID: 30576868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Data on
    Tang Z; Tang G; Hu S; Patel KP; Cameron Yin C; Wang W; Lin P; Toruner GA; Ok CY; Gu J; Lu X; Khoury JD; Jeffrey Medeiros L
    Data Brief; 2019 Jun; 24():104025. PubMed ID: 31193989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complex chromosomal rearrangements leading to MECOM overexpression are recurrent in myeloid malignancies with various 3q abnormalities.
    Baldazzi C; Luatti S; Zuffa E; Papayannidis C; Ottaviani E; Marzocchi G; Ameli G; Bardi MA; Bonaldi L; Paolini R; Gurrieri C; Rigolin GM; Cuneo A; Martinelli G; Cavo M; Testoni N
    Genes Chromosomes Cancer; 2016 Apr; 55(4):375-88. PubMed ID: 26815134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MECOM rearrangement involving the MYC locus: Two additional patients with the rare translocation, t(3;8)(q26.2;q24), and molecular review.
    Smith SC; Qdaisat TZS; Althof PA; Dave BJ; Sanmann JN
    Leuk Res; 2020 Aug; 95():106387. PubMed ID: 32535247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and biological characteristics of adult de novo and secondary acute myeloid leukemia with balanced 11q23 chromosomal anomaly or MLL gene rearrangement compared to cases with unbalanced 11q23 anomaly: confirmation of the existence of different entities with 11q23 breakpoint.
    Archimbaud E; Charrin C; Magaud JP; Campos L; Thomas X; Fière D; Rimokh R
    Leukemia; 1998 Jan; 12(1):25-33. PubMed ID: 9436917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. H2AFY is a novel fusion partner of MECOM in acute myeloid leukemia.
    Han Q; Lu J; Wang J; Ye J; Jiang X; Chen H; Liu C; Chen L; Lin T; Chen S; Sun M; Gao F
    Cancer Genet; 2018 Apr; 222-223():9-12. PubMed ID: 29666008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EVI1-mediated down regulation of MIR449A is essential for the survival of EVI1 positive leukaemic cells.
    De Weer A; Van der Meulen J; Rondou P; Taghon T; Konrad TA; De Preter K; Mestdagh P; Van Maerken T; Van Roy N; Jeison M; Yaniv I; Cauwelier B; Noens L; Poirel HA; Vandenberghe P; Lambert F; De Paepe A; Sánchez MG; Odero M; Verhasselt B; Philippé J; Vandesompele J; Wieser R; Dastugue N; Van Vlierberghe P; Poppe B; Speleman F
    Br J Haematol; 2011 Aug; 154(3):337-48. PubMed ID: 21569010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MECOM (EVI1) Rearrangements: A Review and Case Report of Two MDS Patients with Complex 3q Inversion/Deletions.
    Lawce H; Szabo E; Torimaru Y; Davis C; Osterberg K; Olson S; Moore S
    J Assoc Genet Technol; 2017; 43(1):9-14. PubMed ID: 28459701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of BCR/ABL gene rearrangements by interphase fluorescence in situ hybridization (FISH) in BCR/ABL+ leukemias: incidence and underlying genetic abnormalities.
    Primo D; Tabernero MD; Rasillo A; Sayagués JM; Espinosa AB; Chillón MC; Garcia-Sanz R; Gutierrez N; Giralt M; Hagemeijer A; San Miguel JF; Orfao A
    Leukemia; 2003 Jun; 17(6):1124-9. PubMed ID: 12764379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secondary acquisition of BCR-ABL1 fusion in de novo GATA2-MECOM positive acute myeloid leukemia with subsequent emergence of a rare KMT2A-ASXL2 fusion.
    Blackburn PR; Huang L; Dalovisio A; Pitel BA; Chen D; Oliveira JL; Wood AJ; Smadbeck JB; Johnson SH; Vasmatzis G; Haferlach C; Greipp PT; Hoppman NL; Ketterling RP; Baughn LB; Peterson JF
    Cancer Genet; 2020 Feb; 241():67-71. PubMed ID: 31902694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Translocations and amplifications of chromosome 12 in liposarcoma demonstrated by the LSI CHOP breakapart rearrangement probe.
    Willmore-Payne C; Holden J; Turner KC; Proia A; Layfield LJ
    Arch Pathol Lab Med; 2008 Jun; 132(6):952-7. PubMed ID: 18517278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zebrafish nephrogenesis is regulated by interactions between retinoic acid, mecom, and Notch signaling.
    Li Y; Cheng CN; Verdun VA; Wingert RA
    Dev Biol; 2014 Feb; 386(1):111-22. PubMed ID: 24309209
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Ripperger T; Hofmann W; Koch JC; Shirneshan K; Haase D; Wulf G; Issing PR; Karnebogen M; Schmidt G; Auber B; Schlegelberger B; Illig T; Zirn B; Steinemann D
    Haematologica; 2018 Feb; 103(2):e55-e58. PubMed ID: 29097497
    [No Abstract]   [Full Text] [Related]  

  • 20. "Home-brew" FISH assay shows higher efficiency than BCR-ABL dual color, dual fusion probe in detecting microdeletions and complex rearrangements associated with t(9;22) in chronic myeloid leukemia.
    Albano F; Anelli L; Zagaria A; Archidiacono N; Liso V; Specchia G; Rocchi M
    Cancer Genet Cytogenet; 2007 Apr; 174(2):121-6. PubMed ID: 17452253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.